E.I.D.- Parry (India) Limited
Valuation (84/100) does the heavy lifting; momentum (28/100) is the drag.
Buy zoneSolvency riskOur blended model reads E.I.D.- Parry (India) Limited as a Sell at 40/100. On 23.8x trailing earnings it sits roughly in line with the Basic Materials median of about 22.2x. The price is about 38% below its 52-week high of ₹1,233.5 and 8% above the low of ₹704.1. Financial health scores 34/100, in the grey band on the Altman Z-score, with a Piotroski F-score of 5/9. The average analyst target of ₹1,166 implies about 53% upside across 1 analysts. It clears 5 of 12 investability checks, with durability 39, valuation 68 and momentum 28 on our 0–100 scales.
Analysis by Ankit Sharma · StocksWizard's own estimates from end-of-day public data — see how we calculate them. For information only, not investment advice.
With a 20% margin of safety, our buy-below price is ₹996.73.
Analyst views
1-year price
EOD · 2026-07-3152-week range
-38.38% from the 52-week high.
Price above both moving averages reads as an intact uptrend; below both, the trend is against you.
Verdict pillars
Sell40Piotroski F-score 5/9 — quality of earnings & balance sheet.
Our scores
Durability rewards strong, low-debt, profitable businesses; Valuation rewards stocks cheap vs their sector; Momentum rewards strong price trends.
Investability checklist
- Fail: ROE above 15%: 9.9%
- Pass: Low debt (D/E < 0.5): 0.24x
- Fail: Positive free cash flow
- Pass: Revenue growth > 10%: 16%
- No data: Earnings growing
- Fail: Net margin ≥ 10%: 1.5%
- Fail: Current ratio > 1.5: 1.42
- Pass: Below our fair value
- Pass: Margin of safety ≥ 20%
- Fail: Above 200-day average
- Pass: Above 50-day average
- No data: Positive 1-year return
- Fail: Altman Z in safe zone: Z 2.37
- Fail: Piotroski ≥ 7: 5/9
Quarterly results
Annual financials
Shareholding
- Promoter48.2%
- Institutions23.2%
- Public & other28.7%
Promoter holding via insider stake; institutional via reported holdings.
Key fundamentals
Bull case vs bear case
Bull case
Strengths
- Lightly leveraged balance sheet.
Opportunities
- Revenue growing (16% YoY).
- Trading in our value buy zone versus sector peers.
- Well off its 52-week high — possible mean-reversion.
- Trades ~64% below our estimated fair value.
Bear case
Weaknesses
- Price below its 200-day moving average (downtrend).
About E.I.D.- Parry (India) Limited
E.I.D.- Parry (India) Limited manufactures and sells sugar, nutraceuticals, and distillery products across India, North America, Europe, and other international markets. The company supplies sugar to food, bakery, confectionery, beverage, and pharmaceutical industries, alongside grains including millets, dhals, and rice. It also produces nutraceutical products such as organic spirulina, chlorella, carotenoid, and astaxanthin.
E.I.D.- Parry (India) Limited — frequently asked questions
Is E.I.D.- Parry (India) Limited a buy, hold or sell?
StocksWizard currently rates E.I.D.- Parry (India) Limited (EIDPARRY) a Sell, based on a blended score of 40/100 across valuation, quality, momentum and price trend. This is our own model-based view, not investment advice.
What is E.I.D.- Parry (India) Limited's fair value?
Our blended DCF and relative-valuation model estimates E.I.D.- Parry (India) Limited's fair value at about ₹1,245.91, versus a current price of ₹760.05 — roughly 64% upside. On that basis the stock looks undervalued by 64%.
Is E.I.D.- Parry (India) Limited financially healthy?
E.I.D.- Parry (India) Limited scores 34/100 on our financial-health model, placing it in the grey band on the Altman Z-score, with a Piotroski F-score of 5/9.
How has E.I.D.- Parry (India) Limited's share price performed?
E.I.D.- Parry (India) Limited is down 10% over three months, and last traded at ₹760.05. Past performance doesn't predict future returns.
More in Basic Materials
View allOur verdict, fair value, financial-health and checklist are StocksWizard's own estimates, computed from public end-of-day data using standard models (DCF, relative valuation, Altman Z, Piotroski). For information only — not investment advice or a recommendation. Verify independently before investing.